1Y Close · As of Aug 26, 2026
Amicogen operates in the Food Products sector.
Legal name: Amicogen, Inc.
In fiscal year 2025, Amicogen (092040) reported revenue of 42.0 billion KRW, down 75.8% from 173.6 billion KRW a year earlier.
Operating profit was -17.1 billion KRW and net income was -30.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 68.1 billion KRW, with a P/B of 0.71.
These figures can be verified in the DART filing (receipt no. 20260430001612).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 42.0B | -17.1B | -30.4B |
| 2024 | 173.6B | -7.1B | -50.9B |
| 2023 | 159.9B | 2.1B | -20.7B |
| 2022 | 144.3B | -4.9B | -45.8B |
| 2021 | 124.9B | -4.6B | 4.7B |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Unable to determine due to missing data.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-10 | Officer/Major Shareholder Ownership Report |